AZ01 Interferon β trial for relapsing remitting MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

AZ01 Interferon β trial for relapsing remitting MS

Postby MSUK » Tue Jan 11, 2011 7:35 am

Image

Allozyne, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis.

The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.

The results demonstrate that single administrations of AZ01 were well tolerated at all dosage levels tested. In addition, drug serum levels and interferon activity biomarkers were maintained well after administration in the highest dose groups indicating that once a month dosing may be a viable treatment regimen to pursue.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3055
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2212
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service